CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- 4 Planned sale CHIEF MEDICAL OFFICER sold 40,000 shares at an average $44.82 ($1,792,940)
- 144 Insider Sale of Securities
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale Director sold 2,800 shares at $45.00 ($126,000)
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 17,845 shares at an average $43.28 ($772,254)
- 4 Planned sale Director sold 15,960 shares at an average $45.22 ($721,635)
- 4 Option exercise Director acquired 683 shares (option exercise)
- 8-K Event Executive or director change
- 8-K Event Results of operations
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 12,000 shares at $41.89 ($502,680)
- 4 Planned sale Director sold 20,129 shares at $41.51 ($835,555)
- 4 Planned sale CHIEF OPERATING OFFICER sold 12,048 shares at $41.56 ($500,715)
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 42,841 shares at $41.49 ($1,777,473)
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF OPERATING OFFICER sold 200 shares at $42.89 ($8,578)
- 144 Insider Sale of Securities
Page 5 of 39 · 778 filings